• Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer
  • Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer
  • Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer
  • Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer
  • Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer

Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer

Powder: Yes
Customized: Non-Customized
Certification: Enterprise Standards
Suitable for: Adult
State: Powder
Purity: >98%
Customization:
Diamond Member Since 2016

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory, Trading Company

Basic Info.

Model NO.
HHD Pharm
Color
White
Grade
Pharmaceutical Grade
Transport Package
Alumininum Foli Bags
Specification
10g, 50g, 200g, 1kg, 5kg
Trademark
hhdpharm
Origin
China

Product Description


Wuhan HHD Supply Erlotinib hydrochloride Erlotinib HCL CAS 183319-69-9 Erlotinib for Pancreatic Cancer
Product Name
Erlotinib Hydrochloride
Appearance
 White Powder
Assay
99%min, 98.0% --101.0%
Test
HPLC 
Certificate
ISO 9001 
CAS
183319-69-9
MF C22H24ClN3O4
Storage Temperature
Cool Dry Place


Cephalosporins are widely used antibiotics. Semi-synthetic antibiotics containing cephem in cephalosporin molecules, belonging to β-lactam antibiotics, are derivatives of 7-aminocephalosporanic acid (7-ACA) in β-lactam antibiotics, so they have similar sterilization mechanism. This class of drugs can destroy the cell wall of bacteria and kill bacteria during the reproductive period. It has a strong selective effect on bacteria, but has almost no toxicity to humans. It has the advantages of broad antibacterial spectrum, strong antibacterial effect, resistance to penicillinase, and less allergic reactions than penicillins. Therefore, it is an important antibiotic with high efficiency, low toxicity and wide clinical application.



 

Hhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic CancerHhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic CancerHhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic CancerHhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic CancerHhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic CancerHhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic CancerHhdpharm Erlotinib Hydrochloride Erlotinib HCl CAS 183319-69-9 Pancreatic Cancer

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2016

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory, Trading Company
Registered Capital
1000000 RMB
Plant Area
501~1000 square meters